← Back to Search

Dietary Supplement

Postnatal Dietary Supplement for Healthy Subjects

N/A
Waitlist Available
Led By Gabriele Gratton, Ph.D., M.D.
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Intention to breast feed for at least the first 3 months
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months of age
Awards & highlights

Study Summary

This project will investigate whether adding nutritional supplements to the diet will have beneficial effects on the development of infant brain networks (assessed at 4 and 9 months of age). The nutritional supplement will contain lutein (typically found in leafy vegetables),docosahexaenoic acid (DHA; a fatty acid typically found in cold-water fish such as salmon or tuna), and of vitamin E.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months of age
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months of age for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brain Imaging (Event-Related Optical Signal) of breastfed 4 month old infant
Brain Imaging (Event-Related Optical Signal) of breastfed 9 month old infant
Secondary outcome measures
Infant Dry Blood Spot at 4 months
Infant Dry Blood Spot at 9 months

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Postnatal Dietary SupplementExperimental Treatment1 Intervention
Dietary Supplement: docosahexaenoic acid, lutein, and α-tocopherol (vitamin E). 1 capsule per day will be consumed beginning immediately after birth and continuing for 9 months.
Group II: Control SupplementPlacebo Group1 Intervention
Control Supplement: Capsule containing soybean oil and α-tocopheryl (vitamin E). 1 capsule per day will be consumed beginning immediately after birth and continuing for 9 months.

Find a Location

Who is running the clinical trial?

University of Illinois at Urbana-ChampaignLead Sponsor
188 Previous Clinical Trials
37,265 Total Patients Enrolled
Gabriele Gratton, Ph.D., M.D.Principal InvestigatorUniversity of Illinois at Chicago

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Mar 2025